SAN DIEGO, Aug. 8, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today unveiled a new brand identity that highlights the company's commitment to the life science industry by delivering state-of-the-art laboratories and office spaces to meet the unique needs of its tenants. The brand identity features an energetic new look comprised of a monogram logo in the stylized shape of the company's initials and NYSE ticker symbol, BMR, and a new tagline, Discover here™.
"BioMed Realty has experienced tremendous growth since our inception in 2004 through an unwavering dedication to our tenants and the leveraging of our specialty expertise in life science real estate to build valuable relationships that enable successes in the life science industry," said Alan D. Gold, the company's Chairman and Chief Executive Officer. "Our refreshed logo is inspired by a monogram which represents the heritage of a proven and pioneering business model executed by our skilled employees, the pride of ownership of our premier properties across the core U.S. life science markets and now Europe, and the values we share with our life science partners. To complement our modernized logo, we are pleased to introduce a new tagline, Discover here, which succinctly communicates the essence of our brand story and aspirations."
The monogram's interlocking letters symbolize BioMed Realty's innovative approach in support of its tenants' ongoing research and reflect the personal interaction and close relationships forged with tenants since the company was founded eight years ago. The tagline highlights the groundbreaking advancements in life science research occurring at BioMed Realty's properties, while inviting investors and life science professionals to learn how the company consistently creates long-term value.
Beginning today with the launch of a rebranded website at www.biomedrealty.com, which features enhanced navigation and access to multi-media content for the company's stakeholders, the transition to BioMed Realty's new brand identity will continue over the next several months.
Commenting on the implementation of the new brand identity, Kent Griffin, President of BioMed Realty, remarked, "Our new visual identity is designed to increase the company's brand recognition, which will help position BioMed Realty for continued growth. We are very excited about our refreshed brand and believe that this new visual identity accurately reflects our commitment to our tenants: turning our trusted expertise and reliable service into partnerships that contribute to life science industry successes."
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in properties comprising approximately 13.1 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Francisco, San Diego, Maryland, New York/New Jersey, Pennsylvania and Seattle, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties include, without limitation: general risks affecting the real estate industry (including, without limitation, the inability to enter into or renew leases, dependence on tenants' financial condition, and competition from other developers, owners and operators of real estate); adverse economic or real estate developments in the life science industry or the company's target markets; risks associated with the availability and terms of financing, the use of debt to fund acquisitions, developments and other investments, and the ability to refinance indebtedness as it comes due; failure to maintain the company's investment grade credit ratings with the ratings agencies; failure to manage effectively the company's growth and expansion into new markets, or to complete or integrate acquisitions and developments successfully; reductions in asset valuations and related impairment charges; risks and uncertainties affecting property development and construction; risks associated with downturns in foreign, domestic and local economies, changes in interest rates and foreign currency exchange rates, and volatility in the securities markets; ownership of properties outside of the United States that subject the company to different and potentially greater risks than those associated with the company's domestic operations; risks associated with the company's investments in loans, including borrower defaults and potential principal losses; potential liability for uninsured losses and environmental contamination; risks associated with the company's potential failure to qualify as a REIT under the Internal Revenue Code of 1986, as amended, and possible adverse changes in tax and environmental laws; and risks associated with the company's dependence on key personnel whose continued service is not guaranteed. For a further list and description of such risks and uncertainties, see the reports filed by the company with the Securities and Exchange Commission, including the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
|SOURCE BioMed Realty Trust, Inc.|
Copyright©2012 PR Newswire.
All rights reserved